Calcitonin Gene Related Peptide (CGRP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Jun 2022	79	Global Markets Direct	ASDR-607654

Published: Jun 2022 - Pages : 79 - Publisher : Global Markets Direct - Report code : ASDR-607654

Acherx LLC
AfaSci Inc
Eli Lilly and Co
H. Lundbeck AS
Kissei Pharmaceutical Co Ltd
Nepsone ehf
Pharmnovo AB
Shandong Boan Biotechnology Co Ltd
Shanghai Junshi Bioscience Co Ltd
Teva Pharmaceutical Industries Ltd
Vaxxinity Inc

Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) Drugs in Development by Th...

Published: May, 2022 | Report code: ASDR-601523